Post-Pandemic: How A New Era of Supplier-Vender Collaboration Is Transforming Biopharma

The biopharma industry finds itself at crossroads in 2023. COVID-19 showed the old approaches cannot comfortably cope with disruption, but the industry is yet to settle on a new model. One thing is certain: collaboration between vendors and customers will be critical to shaping all aspects of the future, from building more resilient supply chains to unlocking the potential of novel modalities.